Key takeaways:
Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) contains three active ingredients that decrease inflammation and relax the air passages in the lungs. The inhaler is used for the long-term treatment of chronic obstructive pulmonary disease (COPD) and asthma.
If you don’t have insurance, the amount you will pay for Trelegy Ellipta depends on where you live, your pharmacy, your dosage, and whether you qualify for any discounts or coupons. The average cost of one 100 mcg / 62.5 mcg / 25 mcg inhaler is about $824.55 without insurance.
You may be able to pay less for Trelegy Ellipta by using a GoodRx coupon or comparing prices at different pharmacies. You also may be able to save between $100 and $500 on your monthly prescriptions through GSK’s Trelegy savings program.
Having asthma or chronic obstructive pulmonary disease (COPD) can make breathing difficult, and for some people, lead to a poor quality of life. Trelegy Ellipta is a brand-name, once-daily inhaler that can help make it easier for people with these conditions to breathe.
Trelegy Ellipta contains three active ingredients: fluticasone, umeclidinium, and vilanterol. Fluticasone decreases inflammation in the lungs, while umeclidinium and vilanterol relax the air passages in the lungs. Trelegy Ellipta is not a rescue inhaler, so it won’t relieve sudden or emergency breathing problems. Instead, it can offer long-term relief as a maintenance treatment.
Since Trelegy Ellipta utilizes three active ingredients and there is currently no generic version of the inhaler, it may cost more than some alternative medications. Without insurance or discounts, the average cost of one 100 mcg / 62.5 mcg / 25 mcg inhaler is around $824.55.
The chart below provides a summary of basic information about Trelegy Ellipta.
Brand name | Trelegy Ellipta |
Generic name | No generic available |
Available doses |
|
Recommended dosages |
|
FDA-approved uses |
|
Benefits |
|
Possible side effects |
|
The vast majority of health insurance plans cover Trelegy Ellipta. If you have insurance, check your plan’s summary of benefits and coverage and formulary to determine whether Trelegy Ellipta is covered.
If you have commercial insurance and your plan doesn’t fully cover Trelegy Ellipta, you may be able to save up to $500 per month for 3 months, or up to $200 per month for 9 months, with a copay savings card. You can join the Trelegy savings program to see if you are eligible for any discounts. Your healthcare professional can also order copay savings cards for their office.
As mentioned, Trelegy Ellipta is covered for almost everyone with insurance. And most health insurance providers don’t require enrollees to get a prior authorization or do step therapy for Trelegy Ellipta. However, Medicaid requires a prior authorization for more than 70% of enrollees and step therapy for more than 40% of enrollees.
The following table shows the likelihood of having coverage, as well as prior authorization and step therapy requirements, for the Trelegy Ellipta 100 mcg / 62.5 mcg / 25 mcg inhaler with different types of insurance plans.
Insurance type | Enrollees covered for Trelegy Ellipta | Enrollees required to get a prior authorization | Enrollees required to do step therapy |
Affordable Care Act (ACA) plans | 95.9% | 5.4% | 2.62% |
Commercial (not including ACA) plans | 97.7% | 5.3% | 1.37% |
Medicare, including original Medicare and Medicare Advantage plans | 96% | 0% | 0.03% |
Medicaid, including state-run and managed care plans | 99.9% | 72.1% | 41.98% |
Source: Managed Markets Insight & Technology, LLC™, as of November 13, 2024. (See methodology below.)
Trelegy Ellipta contains multiple medications. Trelegy Ellipta is a long-acting maintenance asthma inhaler that contains several medications to help people get a handle on their symptoms.
A guide to using Trelegy Ellipta inhalers: Learn how to use the inhalers for asthma or chronic obstructive pulmonary disease (COPD).
Comparing the costs of asthma inhalers: See how Trelegy Ellipta measures up to other inhalers and find out ways to save on your prescriptions.
If your insurance doesn’t cover Trelegy Ellipta, here are a few options to try:
Talk to your prescriber about alternative medications.
Ask for a formulary exception from your insurance plan. Keep in mind that you may be required to do step therapy or get a prior authorization to be covered.
If you request a formulary exception and it’s denied, file an appeal with your plan.
Use a GoodRx coupon for potential savings.
Consider changing your prescription medication coverage during your next open enrollment period.
Check if you’re eligible for savings through GSK’s patient assistance program for people without insurance. Or if you have commercial insurance, see if you qualify for a copay savings card.
Without insurance, the average cost of one 100 mcg / 62.5 mcg / 25 mcg Trelegy Ellipta inhaler is about $824.55. However, the exact price you pay will depend on factors such as:
Your dosage
Your geographic location
Your specific pharmacy
Dosage form (1 inhaler) | Average cash price |
---|---|
100 mcg / 62.5 mcg / 25 mcg | |
200 mcg / 62.5 mcg / 25 mcg |
Below are six potential ways to save on Trelegy Ellipta without insurance.
With a GoodRx coupon, you may be able to pay a lower price for your Trelegy Ellipta prescription. At certain pharmacies, one 100 mcg / 62.5 mcg / 25 mcg inhaler may cost as low as $659.81 with a GoodRx coupon.
Here’s how to get a coupon:
Visit www.goodrx.com or install the GoodRx app on your mobile device.
Type “Trelegy Ellipta” in the search field.
Select the correct dose and quantity, and set your location.
Click or tap on “Search prices” to find prices at pharmacies near you.
Choose to receive your coupon via text or email, or print it out.
Show the coupon at the pharmacy when you pick up your medication. Or present the coupon to your pharmacy staff early on in the filling process, such as when you first receive your prescription, to help prevent delays at the pick-up counter.
Ask your prescriber for a prescription for multiple inhalers. Filling multiple inhalers at once may reduce the cost for each individual inhaler.
If you have insurance that covers Trelegy Ellipta, you can also ask about potential discounts for using your plan’s mail-order pharmacy.
GoodRx can help you easily compare costs at different pharmacies so that you can find the best Trelegy Ellipta price in your area.
If you are concerned about the cost of Trelegy Ellipta, talk to your prescriber. There may be another medication that adequately treats your condition and fits your budget.
If you have a health savings account (HSA), a flexible spending account (FSA) or a health reimbursement arrangement (HRA), using those funds to buy your medication can reduce your out-of-pocket costs through tax savings.
GSK, the manufacturer of Trelegy Ellipta, offers a patient assistance program for people without insurance, as well as assistance through its patient access foundation.
Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) is a maintenance inhaler that is used for the long-term treatment of chronic obstructive pulmonary disease (COPD) and asthma. It contains three active ingredients that, together, help decrease inflammation and relax the air passages in the lungs.
Even without insurance, there are ways to save on Treley Ellipta. For example, the cost of one 100 mcg / 62.5 mcg / 25 mcg inhaler may be as low as $659.81 with a GoodRx coupon at certain pharmacies. And GSK, the maker of Trelegy Ellipta, offers multiple programs to help consumers reduce their out-of-pocket costs.
We obtained national prescription coverage data for each medication from Managed Markets Insight & Technology (MMIT). The data reflects health insurance coverage as of November 2024.
We calculated the percentage of enrollees in plans that cover each medication by dividing the number of enrollees covered for the medication within a specific insurance channel (e.g., ACA, Medicare, Medicaid) by the total number of enrollees in all plans within that channel.
We determined the percentage of enrollees in plans with a prior authorization requirement by calculating the proportion of enrollees in plans that required prior authorization for the medication within each channel.
Finally, we measured the percentage of enrollees in plans with a step therapy requirement by calculating the proportion of enrollees in plans that imposed step therapy requirements for the medication in each channel.
These estimates, derived from national MMIT coverage data, provide insight into health insurance coverage for each medication. They take into account restrictions such as prior authorization, step therapy, and quantity limits. The percentages are expressed relative to the total number of enrollees covered by various insurance channels, including ACA plans, commercial (excluding ACA) plans, Medicare, and Medicaid (both state-run and managed care plans).
GlaxoSmithKline. (2023). Trelegy Ellipta - fluticasone furoate, umeclidinium bromide and vilanterol trifenatate powder [package insert].
GSK. (n.d.). Eligibility and enrollment for uninsured patients.
Medicaid.gov. (n.d.). Managed care. Centers for Medicare & Medicaid Services.
Trelegy Ellipta. (n.d.). Request Trelegy samples and savings offers.
Trelegy Ellipta. (n.d.). Trelegy: Savings and support.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.